Study of RO6807952 in Patients With Diabetes Mellitus Type 2

NCT01516476 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

2

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus Type 2

Interventions

DRUG: Placebo
DRUG: RO6807952
DRUG: RO6807952
DRUG: liraglutide

Sponsor

Hoffmann-La Roche